EP1663290A4 - Modulateurs du ligand 1 de la glycoproteine p-selectine - Google Patents

Modulateurs du ligand 1 de la glycoproteine p-selectine

Info

Publication number
EP1663290A4
EP1663290A4 EP04783669A EP04783669A EP1663290A4 EP 1663290 A4 EP1663290 A4 EP 1663290A4 EP 04783669 A EP04783669 A EP 04783669A EP 04783669 A EP04783669 A EP 04783669A EP 1663290 A4 EP1663290 A4 EP 1663290A4
Authority
EP
European Patent Office
Prior art keywords
modulators
glycoprotein ligand
selectin glycoprotein
selectin
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04783669A
Other languages
German (de)
English (en)
Other versions
EP1663290A2 (fr
Inventor
Rong-Hwa Lin
Chung Nan Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abgenomics Cooperatief UA
Original Assignee
Abgenomics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/662,906 external-priority patent/US20040116333A1/en
Application filed by Abgenomics Corp filed Critical Abgenomics Corp
Publication of EP1663290A2 publication Critical patent/EP1663290A2/fr
Publication of EP1663290A4 publication Critical patent/EP1663290A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP04783669A 2003-09-15 2004-09-09 Modulateurs du ligand 1 de la glycoproteine p-selectine Withdrawn EP1663290A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/662,906 US20040116333A1 (en) 2001-08-03 2003-09-15 Modulators of P-selectin glycoprotein ligand 1
PCT/US2004/029520 WO2005027831A2 (fr) 2001-08-03 2004-09-09 Modulateurs du ligand 1 de la glycoproteine p-selectine

Publications (2)

Publication Number Publication Date
EP1663290A2 EP1663290A2 (fr) 2006-06-07
EP1663290A4 true EP1663290A4 (fr) 2009-07-01

Family

ID=36242362

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04783669A Withdrawn EP1663290A4 (fr) 2003-09-15 2004-09-09 Modulateurs du ligand 1 de la glycoproteine p-selectine

Country Status (16)

Country Link
EP (1) EP1663290A4 (fr)
JP (1) JP5808879B2 (fr)
KR (1) KR101159140B1 (fr)
CN (1) CN1852730B (fr)
AU (1) AU2004273807B2 (fr)
BR (1) BRPI0414402A (fr)
CA (1) CA2538284C (fr)
EC (1) ECSP066507A (fr)
IL (1) IL174172A (fr)
NO (1) NO20061306L (fr)
NZ (1) NZ546203A (fr)
RU (1) RU2407539C2 (fr)
SG (1) SG146670A1 (fr)
TW (2) TWI359024B (fr)
UA (1) UA91004C2 (fr)
ZA (1) ZA200602151B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120085921A (ko) * 2004-05-11 2012-08-01 압제노믹스 코오페라티에프 유.에이. Ｔ 세포 사멸 유도성 에피토프
WO2009139459A1 (fr) * 2008-05-15 2009-11-19 国立大学法人 岡山大学 Procédé pour la prévention et le traitement du syndrome métabolique par l'inhibition de psgl-1
US10472422B2 (en) * 2016-01-08 2019-11-12 Abgenomics International Inc. Tetravalent anti-PSGL-1 antibodies and uses thereof
CN115887659A (zh) * 2022-11-23 2023-04-04 中山大学附属第七医院(深圳) 终末耗竭t细胞群“tcf19+pd1+tim3+cd8+”的鉴定及应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997040154A1 (fr) * 1996-04-24 1997-10-30 Genentech, Inc. Lectines de type c
US6117977A (en) * 1996-04-24 2000-09-12 Genentech, Inc. Type C lectins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68913658T3 (de) * 1988-11-11 2005-07-21 Stratagene, La Jolla Klonierung von Immunglobulin Sequenzen aus den variablen Domänen
US5843707A (en) * 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
US7744888B2 (en) * 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997040154A1 (fr) * 1996-04-24 1997-10-30 Genentech, Inc. Lectines de type c
US6117977A (en) * 1996-04-24 2000-09-12 Genentech, Inc. Type C lectins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DAMLE N K ET AL: "GMP-140 (P-SELECTIN/CD62) BINDS TO CHRONICALLY STIMULATED BUT NOT RESTING CD4+ T LYMPHOCYTES AND REGULATES THEIR PRODUCTION OF PROINFLAMMATORY CYTOKINES", EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY - V C H VERLAG GMBH & CO. KGAA, DE, vol. 22, no. 7, 1 January 1992 (1992-01-01), pages 1789 - 1793, XP000655066, ISSN: 0014-2980 *
KUNZENDORF U ET AL: "T cells bind to the endothelial adhesion molecule GMP-140 (P-selectin).", TRANSPLANTATION NOV 1993, vol. 56, no. 5, November 1993 (1993-11-01), pages 1213 - 1217, XP002528704, ISSN: 0041-1337 *
See also references of WO2005027831A2 *

Also Published As

Publication number Publication date
ECSP066507A (es) 2006-10-10
ZA200602151B (en) 2013-08-28
CN1852730B (zh) 2012-05-30
KR101159140B1 (ko) 2012-06-22
TWI359024B (en) 2012-03-01
NO20061306L (no) 2006-06-14
RU2407539C2 (ru) 2010-12-27
KR20060088104A (ko) 2006-08-03
UA91004C2 (uk) 2010-06-25
TW200513262A (en) 2005-04-16
CA2538284C (fr) 2015-10-20
CA2538284A1 (fr) 2005-03-31
AU2004273807A1 (en) 2005-03-31
BRPI0414402A (pt) 2006-11-14
CN1852730A (zh) 2006-10-25
JP5808879B2 (ja) 2015-11-10
RU2006112399A (ru) 2006-08-10
EP1663290A2 (fr) 2006-06-07
SG146670A1 (en) 2008-10-30
IL174172A (en) 2011-12-29
JP2007533618A (ja) 2007-11-22
TW201012472A (en) 2010-04-01
NZ546203A (en) 2009-05-31
IL174172A0 (en) 2006-08-01
AU2004273807B2 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
GB0201203D0 (en) Modulators
IL173672A0 (en) Separable modulator
PL379551A1 (pl) Ciekły wybielający żel do zębów
EP1398252A4 (fr) Vehicule a chenilles detachables
GB0120366D0 (en) Nanostructure synthesis
IL158958A0 (en) 5-substituted-2-arylpyridines as crfi modulators
IL176215A0 (en) Modulators of muscarinic receptors
EP1666954A4 (fr) Modulateur optique
GB0123379D0 (en) Modulators
GB2422544B (en) Immune modulator
AU2002357219A8 (en) Frequency-down-converter using sigma-delta modulators
GB2407131B (en) Modulator
GB0306575D0 (en) Modulators
GB2386965B (en) Electro-optic modulators
ZA200602151B (en) Modulators of p-selectin glycoprotein ligand 1
GB0302465D0 (en) "13C-labelled synthesis"
GB2408811B (en) Optical Modulator
HK1086759A (en) Modulators of p-selectin glycoprotein ligand 1
EP1586282A4 (fr) Fixation pour prothese dentaire
GB0208672D0 (en) Integrated mach-zehnder modulator
GB2372577B (en) Electro-optic modulator
GB2397449B (en) Modulator
GB0212773D0 (en) Modulators
GB0212926D0 (en) Modulators
TW467176U (en) Strutting frame for form

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060322

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL HR LT LV MK

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1086759

Country of ref document: HK

RAX Requested extension states of the european patent have changed

Extension state: HR

Payment date: 20060322

Extension state: LV

Payment date: 20060322

A4 Supplementary search report drawn up and despatched

Effective date: 20090604

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/17 20060101ALI20090525BHEP

Ipc: C07K 14/705 20060101AFI20090525BHEP

Ipc: C07K 16/28 20060101ALI20090525BHEP

17Q First examination report despatched

Effective date: 20090917

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ABGENOMICS COOEPERATIEF U.A.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ABGENOMICS COOEPERATIEF U.A.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180224